While many people think attaining healthy weight loss is as easy as eating a balanced diet and engaging in regular physical ...

Wegovy and similar weight-loss medications are becoming widely prescribed for teenagers with obesity, but little is known ...

As obesity rates in the United States soar, insurance companies, including Medicaid and Medicare, are facing financial headwinds to pay for prescription drugs for weight loss. Semaglutide, the generic ...

Ozempic is arguably the buzziest buzzword in our culture today. But we still have plenty of questions about the type 2 ...

A turbulent series of events around the supply of Eli Lilly’s blockbuster weight loss treatment has raised concerns around ...

Karan Johar's noticeable weight loss has sparked rumours about his possible use of Ozempic, a diabetes drug known for its ...

These include commonly prescribed drugs such as Ozempic or Wegovy (semaglutide), Saxenda (liraglutide), Zepbound (tirzepatide ...

Eli Lilly (NYSE:LLY) is reportedly preparing to launch its drug Mounjaro in Denmark, the home country of its leading rival in the weight-loss drug market, Novo Nordisk (NVO). Lilly (LLY) plans to ...

Companies are figuring out how to cater to consumers using GLP-1 drugs, such as Ozempic.

A Duloxetine recall by the FDA has flagged more than 7,100 bottles of the Cymbalta generic drug due to a cancerous chemical.

The FDA has approved a new drug called zolbetuximab designed to attack a novel target that’s in a type of stomach cancer.

Financial Services Secretary M Nagaraju, who was also present at the ceremony, expressed his happiness with the bank's initiative.